AnaptysBio Corp - ANAB Market Capitalization
AnaptysBio, Inc. (ANAB) relies on its proprietary antibody discovery system, integrating scientific developments into the supply chains of industry behemoths to combat arthritis, while a diversified research portfolio and partnership royalties minimize business risks. This price chart reflects a market capitalization of 1.45. Demand for modern therapies for severe inflammation remains high, fueling interest from global pharmaceutical corporations.
Comprehensive metric breakdowns and analytics for AnaptysBio Inc. (ANAB)
- market price and analyst price targets:
- issuer market value details:
- issuer book value statistics:
- issuer credit burden and liquidity indicators:
Total Debt to Capital AnaptysBio, Inc.|ANAB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital AnaptysBio, Inc.|ANAB - Company Aggregate Debts|Debt to Book Capitalization Ratio AnaptysBio Inc.|ANAB - Company Long-Term Loans and Borrowings|Company Short-Term Debt AnaptysBio|Quick Ratio anaptysbio.com
- financial results and valuation multiples details:
ANAB - Net Profit|Future Profit AnaptysBio, Inc.|ANAB - Company Value to Net Income|Forward P/E Multiple AnaptysBio Corp|ANAB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AnaptysBio Inc.|ANAB - Operating profit before deduction of amortization|Earnings per share for the last twelve months AnaptysBio|ANAB - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months anaptysbio.com|ANAB - Earnings growth in current year|Net earnings per share growth forecast for next year AnaptysBio, Inc.
Fundamental company analysis:ANAB (AnaptysBio)
Market capitalization measures the total value of all outstanding shares, determining an asset's investment attractiveness and its compliance with strict index fund criteria. By analyzing the capitalization dynamics of the issuer, an investor assesses the financial stability of AnaptysBio, Inc. (ANAB), which directly depends on the ability to retain leading biologists to develop innovative antibodies against immune pathologies.
Key competitors
Market Value argenx ARGX|BNTX: Market Capitalization|Abivax S.A. - Market Capitalization|ADMA - Market Capitalization|PTGX: Market Capitalization|IMVT (immunovant.com) - Market Value|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|Aerovate - Market Capitalization|ACRS - Market Capitalization|Kyverna Therapeutics (KYTX) - Market Value|Market Capitalization TLSA|CABA (Cabaletta Bio) - Market Capitalization|Market Capitalization Ventyx Biosciences Inc.|Market Value Theratechnologies Inc (THTX)|AVTX: Market Valuation|Eledon Pharmaceuticals - Market Valuation|Market Value AGEN (agenusbio.com)|CLYM: Market Valuation|Market Value zurabio.com|aTyr (ATYR) - Market Value|ADAG - Market Capitalization|IMA (ImageneBio) - Market Capitalization|Market Value STTK|Market Capitalization EQ|Market Capitalization connectbiopharm.com|Market Value Immunic IMUX|Atara Biotherapeutics, Inc. (ATRA) - Market Value|IFRX: Market Valuation|Market Value XFOR (x4pharma.com)|ACET: Market Capitalization|CELU - Market Capitalization|Market Value INmune Bio Corp|Market Capitalization BRNS (Barinthus Biotherapeutics Corp)|Market Capitalization KZR|Market Valuation sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Market Valuation|Market Capitalization Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp - Market Capitalization|GOVX - Market Capitalization|Edesa Biotech, Inc. (EDSA) - Market Value|Market Capitalization IBIO|CARM (Carisma Therapeutics Inc) - Market Capitalization|Market Capitalization XTL Biopharmaceuticals Ltd|Market Capitalization BOLT|Market Value HCWB (hcwbiologics.com)|Market Value Aptevo Therapeutics Inc. APVO|AIM (aimimmuno.com) - Market Valuation|Aditxt Corp - Market Capitalization|Market Value GRI (GRI Bio Inc)|XRTX: Market Capitalization|Vyome Therapeutics (HIND) - Market Capitalization|Market Value Revelation Biosciences|INDP: Market Value|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|Market Valuation calcimedica.com CALI|Market Capitalization AFMD (Affimed N.V.)|Market Capitalization Allakos Inc ALLK|HOOK: Market Valuation|Market Value IGMS (IGM Biosciences, Inc.)|ITOS: Market Capitalization|OCEA - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
